Health insurers have a unique opportunity to leverage Healthtech startups. This report series looks at a cross-section of interesting companies across a spectrum defined by our parent company Oliver Wyman's Health and Life Sciences practice. This is the second in a series of five reports from and authored by Celent.

In this report we focus on Care Delivery. As with other industries, improvement in the quality of care, including the care experience, is critical. The startups and established vendors profiled here are innovating for the benefit of the entire value chain.

As mentioned in the over report, in each area, we will look at a variety of healthtech firms delivering interesting and useful technology to improve each functional area. There are literally thousands of these companies, which is encouraging for our industry. Clearly we will look at a cross-section.

As always, feedback is welcome!